Morgan Stanley Trinity Biotech PLC Transaction History

Morgan Stanley

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.38 - $0.7 $5,529 - $10,186	14,552 New	14,552 $6,000
Q3 2023 Nov 15, 2023	SELL	$0.68 - $1.08 $16,103 - $25,575	-23,681 Reduced 61.94%	14,552 $10,000
Q1 2023 May 15, 2023	SELL	$0.87 - $1.18 $522 - $708	-600 Reduced 1.55%	38,233 $35,000
Q4 2022 Feb 14, 2023	SELL	$0.98 - $6.15 $5,831 - $36,592	-5,950 Reduced 13.29%	38,833 $38,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $5.45 $2,398 - $11,990	-2,200 Reduced 4.68%	44,783 $48,000
Q2 2022 Oct 27, 2022	SELL	$0.96 - $1.44 $58,438 - $87,657	-60,873 Reduced 56.44%	46,983 $57,000
Q2 2022 Aug 15, 2022	SELL	$0.96 - $1.44 $58,438 - $87,657	-60,873 Reduced 56.44%	46,983 $57,000
Q1 2022 Oct 27, 2022	BUY	$0.92 - $1.44 $56,003 - $87,657	60,873 Added 129.56%	107,856 $115,000
Q1 2022 May 13, 2022	BUY	$0.92 - $1.44 $43,468 - $68,037	47,248 Added 77.96%	107,856 $115,000
Q4 2021 Feb 14, 2022	BUY	$1.43 - $2.25 $56,975 - $89,646	39,843 Added 191.88%	60,608 $87,000
Q3 2021 Nov 15, 2021	BUY	$1.82 - $2.94 $37,792 - $61,049	20,765 New	20,765 $45,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $42.7M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.